HIFU and cryoablation – non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound?

References

• Aus G., Abbou C. C., Bolla M., Heidenreich A., et al. EAU guidelines on prostate cancer. European Urology 2005; 48: 546–51
   PubMed Web of Science ®Google Scholar
• Gage A. A., Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37: 171–86
   PubMed Web of Science ®Google Scholar
• Gonder M. J., Soanes W. A., Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966; 3: 372–8
   PubMedGoogle Scholar
• Soanes W. A., Gonder M. J., Shulman S. Apparatus and technique for cryosurgery of the prostate. J Urol 1966; 96: 508–11
   Google Scholar
• Cohen J. K., Miller R. J., Shuman B. A. Urethral Warming Catheter for Use During Cryoablation of the Prostate. Urology 1995; 45: 861–4
   PubMed Web of Science ®Google Scholar
• Han K. R., Belldegrun A. S. Third‐generation cryosurgery for primary and recurrent prostate cancer. Bju International 2004; 93: 14–8
   PubMed Web of Science ®Google Scholar
• Bahn D. K., Lee F., Silverman P., Bahn E. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: A 7‐year follow‐up. Journal of Urology 2003; 169: 342
   Google Scholar
• Touma N. J., Izawa J. I., Chin J. L. Current status of local salvage therapies following radiation failure for prostate cancer. Journal of Urology 2005; 173: 373–9
   PubMed Web of Science ®Google Scholar
• Katz A. E., Prepelica K. L., Masson P., Benson M. C., et al. Salvage cryosurgical ablation of the prostate (TCAP) for patients failing radiation: 10‐year experience. Journal of Urology 2005; 173: 450–1
   Google Scholar
• Beerlage H. P., van Leenders G. J. L. H., Oosterhof G. O. N., Witjes J. A., et al. High‐intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: Results of a prospective study. Prostate 1999; 39: 41–6
   PubMed Web of Science ®Google Scholar
• Chapelon J. Y., Margonari J., Vernier F., Gorry F., et al. Invivo Effects of High‐Intensity Ultrasound on Prostatic Adenocarcinoma Dunning R3327. Cancer Research 1992; 52: 6353–7
   PubMed Web of Science ®Google Scholar
• Gelet A., Chapelon J. Y., Poissonnier L., Bouvier R., et al. Local recurrence of prostate cancer after external beam radiotherapy: Early experience of salvage therapy using high‐intensity focused ultrasonography. Urology 2004; 63: 625–9
   PubMed Web of Science ®Google Scholar
• Cresswell J., Asterling S., Chaudhary M., Sheikh N., et al. Third‐generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. Bju International 2006; 97969–74
   Google Scholar
• Donnelly B. J., Saliken J. C., Ernst D. S., Ali‐Ridha N., et al. Prospective trial of cryosurgical ablation of the prostate: Five‐year results. Urology 2002; 60: 645–9
   PubMedGoogle Scholar
• Bahn D. K., Lee F., Badalament R., Kumar A., et al. Targeted cryoablation of the prostate: 7‐year outcomes in the primary treatment of prostate cancer. Urology 2002; 60: 3–11
   PubMed Web of Science ®Google Scholar
• Han K. R., Cohen J. K., Miller R. J., Pantuck A. J., et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003; 170: 1126–30
   Google Scholar
• Cytron S., Paz A., Kravchick S., Shumalinski D., et al. Active rectal wall protection using direct transperineal cryo‐needles for histologically proven prostate adenocarcinomas. European Urology 2003; 44: 315–20
   Google Scholar
• Prepelica K. L., Okeke Z., Murphy A., Katz A. E. Cryosurgical ablation of the prostate: High‐risk patient outcomes. Cancer 2005; 103: 1625–30
   Google Scholar
• Blana A., Walter B., Rogenhofer S., Wieland W. F. High‐intensity focused ultrasound for the treatment of localized prostate cancer: 5‐year experience. Urology 2004; 63: 297–300
   PubMed Web of Science ®Google Scholar
• Gelet A., Chapelon J. Y., Bouvier R., Rouviere O., et al. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: Factors influencing the outcome. European Urology 2001; 40: 124–9
   PubMed Web of Science ®Google Scholar
• Poissonnier L., Chapelon J. Y., Rouviere O., Curiel L., et al. Control of Prostate Cancer by Transrectal HIFU in 227 Patients. Eur Urol. 2006, (in print)
   Google Scholar
• Thuroff S., Chaussy C., Vallancien G., Wieland W., et al. High‐intensity focused ultrasound and localized prostate cancer: Efficacy results from the European multicentric study. Journal of Endourology 2003; 17: 673–7
   PubMedGoogle Scholar
• Uchida T., Ohkusa H., Nagata Y., Hyodo T., et al. Treatment of localized prostate cancer using high‐intensity focused ultrasound. Bju International 2006; 97: 56–61
   PubMed Web of Science ®Google Scholar
• Thueroff S., Knauer K., Chaussy C. 10 years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: Profile of side effects. Journal of Urology 2006; 175: 364–5
   Google Scholar
• Chaussy C., Thuroff S. Results and side effects of high‐intensity focused ultrasound in localized prostate cancer. Journal of Endourology 2001; 15: 437–40
   PubMed Web of Science ®Google Scholar
• Thuroff S., Chaussy C. Therapy of localized prostate cancer with high‐intensity focused ultrasound. Results and side effects. Urologe A 2001; 40: 191–4
   Google Scholar
• Chaussy C., Thuroff S. The status of high‐intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248–52
   PubMedGoogle Scholar
• Rebillard X., Gelet A., Davin J. L., Soulie M., et al. Transrectal high‐intensity focused ultrasound in the treatment of localized prostate cancer. Journal of Endourology 2005; 19: 693–701
   PubMed Web of Science ®Google Scholar
• Vallancien G., Prapotnich D., Cathelineau X., Baumert H., et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: Feasibility study. Journal of Urology 2004; 171: 2265–7
   PubMed Web of Science ®Google Scholar
• Shinohara K., Rhee B., Presti J. C., Carroll P. R. Cryosurgical ablation of prostate cancer: Patterns of cancer recurrence. Journal of Urology 1997; 158: 2206–9
   PubMedGoogle Scholar
• Onik G., Narayan P., Vaughan D., Dineen M., et al. Focal “nerve‐sparing” cryosurgery for treatment of primary prostate cancer: A new approach to preserving potency. Urology 2002; 60: 109–14
   PubMedGoogle Scholar
• Janzen N. K., Han K. R., Perry K. T., Said J. W., et al. Feasibility of nerve‐sparing prostate cryosurgery: Applications and limitations in a canine model. Journal of Endourology 2005; 19: 520–5
   Google Scholar
• Norberg M., Egevad L., Holmberg L., Sparen P., et al. The sextant protocol for ultrasound‐guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562–6
   PubMed Web of Science ®Google Scholar
• Wijkstra H., Wink M. H., De la Rosette J. J. M. C. Contrast specific imaging in the detection and localization of prostate cancer. World Journal of Urology 2004; 22: 346–50
   PubMed Web of Science ®Google Scholar
• Aus G. Current Status of HIFU and Cryotherapy in Prostate Cancer ‐ A Review. Eur Urol. 2006, (in print)
   Google Scholar
• Beerlage H. P., Thuroff S., Madersbacher S., Zlotta A. R., et al. Current status of minimally invasive treatment options for localized prostate carcinoma. European Urology 2000; 37: 2–13
   Google Scholar
• Madersbacher S., Pedevilla M., Vingers L., Susani M., et al. Effect of High‐Intensity Focused Ultrasound on Human Prostate‐Cancer In‐Vivo. Cancer Research 1995; 55: 3346–51
   PubMed Web of Science ®Google Scholar
• Uchida T., Ohkusa H., Yamashita H., Shoji S., et al. Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. International Journal of Urology 2006; 3: 228–33
   Google Scholar
• Chaussy C. G., Thuroff S. High‐intensive focused ultrasound in localized prostate cancer. Journal of Endourology 2000; 14: 293–9
   PubMedGoogle Scholar
• Blana A., Rogenhofer S., Ganzer R., Wild P. J., et al. Morbidity associated with repeated transrectal high‐intensity focused ultrasound treatment of localized prostate cancer. World J Urol. 2006, (in print)
   Google Scholar
• Roy C., Buy X., Lang H., Saussine C., et al. Contrast enhanced color Doppler endorectal sonography of the prostate: Efficiency for detecting peripheral zone tumors and role for biopsy procedure. Journal of Urology 2003; 170: 69–72
   Google Scholar
• Halpern E. J., Rosenberg M., Gomella L. G. Prostate cancer: Contrast‐enhanced US for detection. Radiology 2001; 219: 219–25
   PubMed Web of Science ®Google Scholar
• Pelzer A., Bektic J., Berger A. P., Pallwein L., et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. Journal of Urology 2005; 173: 1926–9
   PubMed Web of Science ®Google Scholar
• Sedelaar J. P. M., Aarnink R. G., van Leenders G. J. L. H., Beerlage H. P., et al. The application of three‐dimensional contrast‐enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. European Urology 2000; 37: 559–68
   PubMedGoogle Scholar
• Eckersley R. J., Sedelaar J. P. M., Blomley M. J. K., Wijkstra H., et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 2002; 51256–67
   Google Scholar